WO2020008149A8 - Utilisation d'une souche de roseburia intestinalis pour la prévention et le traitement de l'inflammation de l'intestin - Google Patents

Utilisation d'une souche de roseburia intestinalis pour la prévention et le traitement de l'inflammation de l'intestin Download PDF

Info

Publication number
WO2020008149A8
WO2020008149A8 PCT/FR2019/051660 FR2019051660W WO2020008149A8 WO 2020008149 A8 WO2020008149 A8 WO 2020008149A8 FR 2019051660 W FR2019051660 W FR 2019051660W WO 2020008149 A8 WO2020008149 A8 WO 2020008149A8
Authority
WO
WIPO (PCT)
Prior art keywords
prevention
treatment
inflammatory bowel
bowel disease
roseburia intestinalis
Prior art date
Application number
PCT/FR2019/051660
Other languages
English (en)
Other versions
WO2020008149A1 (fr
Inventor
Marianne DE PAEPE
Jeffrey CORNUAULT
Harry SOKOL
Original Assignee
Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement
Agroparistech (Institut Des Sciences Et Industries Du Vivant Et De L'environnement)
Sorbonne Universite
Assistance Publique - Hôpitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement, Agroparistech (Institut Des Sciences Et Industries Du Vivant Et De L'environnement), Sorbonne Universite, Assistance Publique - Hôpitaux De Paris filed Critical Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement
Publication of WO2020008149A1 publication Critical patent/WO2020008149A1/fr
Publication of WO2020008149A8 publication Critical patent/WO2020008149A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne l'identification d'une bactérie présentant un intérêt particulier comme probiotique et son utilisation dans l'alimentation humaine ou pour le traitement ou la prévention de pathologie inflammatoire.
PCT/FR2019/051660 2018-07-04 2019-07-04 Utilisation d'une souche de roseburia intestinalis pour la prévention et le traitement de l'inflammation de l'intestin WO2020008149A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1856152 2018-07-04
FR1856152A FR3083545A1 (fr) 2018-07-04 2018-07-04 Utilisation d'une souche de roseburia intestinalis pour la prevention et le traitement de l'inflammation de l'intestin

Publications (2)

Publication Number Publication Date
WO2020008149A1 WO2020008149A1 (fr) 2020-01-09
WO2020008149A8 true WO2020008149A8 (fr) 2020-09-17

Family

ID=65200896

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2019/051660 WO2020008149A1 (fr) 2018-07-04 2019-07-04 Utilisation d'une souche de roseburia intestinalis pour la prévention et le traitement de l'inflammation de l'intestin

Country Status (2)

Country Link
FR (1) FR3083545A1 (fr)
WO (1) WO2020008149A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111617099B (zh) * 2020-06-16 2022-12-20 青岛农业大学 一种无抗高细胞亲和性结肠炎修复剂与应用方法
TWI739495B (zh) * 2020-06-29 2021-09-11 豐華生物科技股份有限公司 可促進排便的組合物及其用途
CN114748513A (zh) * 2020-12-29 2022-07-15 中国医学科学院放射医学研究所 肠道罗斯拜瑞氏菌在制备肿瘤的放射增敏剂中的用途
US20220218767A1 (en) * 2021-01-09 2022-07-14 Be Rich Biotechnology Co., Ltd. Blood glucose control and anti-obesity probiotics compositions in a specific selection and ratio
CN113122472B (zh) * 2021-04-08 2022-07-22 江南大学 一株能够保护肠道通透性的普通拟杆菌及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225202A (en) 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
US5733575A (en) 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
AU717817B2 (en) 1996-06-06 2000-04-06 Bifodan A/S Enteric coating, comprising alginic acid, for an oral preparation
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
US6139875A (en) 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
GB201117313D0 (en) * 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
CA2995786A1 (fr) 2015-08-24 2017-03-02 Nubyiota Llc Systemes et procedes pour le traitement d'une dysbiose a l'aide de populations bacteriennes derivees de feces

Also Published As

Publication number Publication date
FR3083545A1 (fr) 2020-01-10
WO2020008149A1 (fr) 2020-01-09

Similar Documents

Publication Publication Date Title
WO2020008149A8 (fr) Utilisation d'une souche de roseburia intestinalis pour la prévention et le traitement de l'inflammation de l'intestin
PH12018500566A1 (en) Novel lactobacillus having various functions, and use thereof
WO2018229236A3 (fr) Compositions comprenant des souches bactériennes
WO2015095241A3 (fr) Compositions bactériennes et leurs méthodes d'utilisation pour traiter des troubles du système immunitaire
MX369877B (es) Composiciones y metodos.
MX2015011700A (es) Uso de la bacteria faecalibacterium prausnitzii htf-f (dsm 26943) para suprimir la inflamacion.
GB2465051A (en) Probiotic bifidobacterium strains
GB2460781A (en) Probiotic bifidobacterium strains
WO2019066599A3 (fr) Nouvelles bactéries d'acide lactique et leur utilisation
SE1550189A1 (en) Therapeutic and prophylactic composition produced by microbiota
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
MX2023000736A (es) Productos microbianos alimentados en directo.
WO2017147130A3 (fr) Produits microbiens administrés directement pour la prévention de la maladie des crevettes
MX2021003224A (es) Combinacion de probioticos para el tratamiento de trastornos gastrointestinales relacionados con la inflamacion.
MY201921A (en) Agent for preventing or treating fat-associated diseases and/or inflammation
EA201992175A1 (ru) Композиции и способы, включающие пробиотические молекулы
MX2021007260A (es) Inhibidores de la vía de cinasa janus 1 (jak1) para el tratamiento de enfermedades gastrointestinales.
WO2021004958A3 (fr) Compositions comprenant des souches bactériennes
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
EP3810088A4 (fr) Amélioration de la santé du microbiome dans un système gastro-intestinal humain et produits de distribution de probiotiques à plusieurs chambres associé
WO2014033574A3 (fr) Probiotiques et produits d'hygiène personnelle stabilisés par une protéine
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.
WO2019022602A8 (fr) Composition pharmaceutique destinée à être utilisée dans le traitement ou la prévention de carences en vitamines et minéraux chez des patients ayant été soumis à une gastrectomie
MX2020001501A (es) Streptococcus australis como bioterapeuticos.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19745195

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19745195

Country of ref document: EP

Kind code of ref document: A1